From: Novel HDAC inhibitor MAKV-8 and imatinib synergistically kill chronic myeloid leukemia cells via inhibition of BCR-ABL/MYC-signaling: effect on imatinib resistance and stem cells
Compounds
Binding affinity (kcal/mol)a
MAKV-6
− 5.9
MAKV-7
− 6.4
MAKV-8
− 7.2
MAKV-10
− 6.9
MAKV-12
− 6.1